Pay in 4 interest-free payments of $17.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Alloatti G
18(17):4764-74
1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain
without modifying seizures acutely
and the IC50 value of the compound against CaM-KII is 10 μg/mL
FLI-06 - Notch Pathway Modulator. CAS# 313967-18-9 Catalog No.:M60149-10S Alloatti GFLI 06, CAS No. 313967 18 9, is a novel potent and selective small molecule intercepting Notch signaling and the early secretory pathway (EC50 ~2. 3 M), identified by using automated microscopy to monitor the trafficking and processing of a ligand independent Notch GFP fusion reporter. FLI 06 can induce accumulation of the reporter at the plasma membrane by interfering with transport in the secretory pathway. It can also disrupt the Golgi apparatus in
US$ 1779.50
US$ 3643.50
US$ 1584.00
US$ 5634.00
US$ 1519.00
US$ 1364.00